Franklin, MA – Prestige Scientific is pleased to announce the successful placement of an Executive Director of Global Regulatory Strategy for our partner, a biotechnology company focused on developing RNA therapies for severe diseases.
This critical hire has over 20 years of regulatory affairs experience spanning large pharmaceutical organizations and emerging biotech companies, with deep expertise in cell and gene therapies, rare diseases, and immuno-oncology. Their background includes leading and contributing to global regulatory submissions such as INDs, NDAs, BLAs, MAAs, and international approvals, and setting global regulatory strategy through early and mid-stage development. They have progressed from academic research supporting early clinical programs to senior leadership roles overseeing regulatory and quality functions, managing agency interactions worldwide, and advising advanced therapy companies as a strategic regulatory partner.
Prestige Scientific presented 11 individuals for this role, the hired candidate was presented in 17 days from the start of the project, and the search was completed in 48 days. Congratulations to our Regulatory search team for this successful project.
About Prestige Scientific:
Prestige Scientific is an executive search firm that advises our clients on recruiting impactful leaders. We provide our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. We have dedicated experts in eleven practice areas that mirror a typical biopharma company, allowing us to support our client's growth from Discovery through Commercial.
